Equity Profile

BLLN

BillionToOne, Inc.

Health CareHealth Care Services$4.6B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

BillionToOne, Inc. operates in the health care sector, focusing on innovative health care services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating income.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and attract more customers, which is crucial for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BLLN Q2-2026 Earnings Preview

Context

Company Snapshot

BillionToOne, Inc. operates in the health care sector, focusing on innovative health care services. The company is known for its advanced diagnostic solutions, which are increasingly important in personalized medicine and patient care.

Earnings Scorecard·Last 3Q

EPS Beat Streak

EPS Beat Rate

67%

Avg EPS Surprise

+1110.58%

Avg Stock Reaction

+1.25%

Last Quarter Recap

In Q1-2026, BillionToOne reported an impressive EPS of $0.34, significantly exceeding expectations. The stock reacted positively, gaining 1.88% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic about BillionToOne's upcoming earnings, especially after a strong performance last quarter. However, uncertainty remains due to the lack of detailed guidance.

Bull Case

If BillionToOne continues to outperform expectations, particularly in EPS and revenue growth, it could solidify its position as a leader in health care diagnostics.

Bear Case

Conversely, if the company fails to meet even its previous performance, it could lead to a significant drop in investor confidence and stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the significant surprise in the last quarter, the market will closely watch EPS to gauge ongoing profitability.

How is revenue growth tracking compared to last quarter?

Revenue growth is critical for investor confidence, and any signs of slowdown could negatively impact stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate BillionToOne's growth potential, especially given its recent strong EPS performance. Investors might overlook the company's ability to sustain momentum in a competitive market.

Supporting Evidence

BillionToOne's last quarter showed a remarkable EPS surprise, indicating strong operational efficiency.

The options market is pricing in a significant move, suggesting that investors expect volatility that could favor the upside.

Key Risk

If the company reports an EPS below $0.20, it could challenge the current optimistic outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be pivotal in determining whether BillionToOne can sustain its growth trajectory or if it faces headwinds.

Bull Confirmed If

An EPS of $0.40 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $0.20 would raise concerns about the company's profitability and future growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±8.89%

Historical Avg

±3.1%

Pricing rich

The options market is pricing in a substantial move, suggesting that investors expect significant volatility around the earnings report.

Options are pricing ±15.1% while BLLN has averaged ±3.1% over the last 3 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

95.0%

Calls (9K)P/C Ratio: 0.35Puts (2K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 27 (48%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 27 faded and 14 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.6%, with a raw directional average of +3.0% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If BillionToOne beats expectations, history suggests the stock could rise around 1.88%, confirming strong operational momentum.

In-Line / Cautious

If results are in line but management expresses caution, the stock may see muted movement as investors digest the commentary.

Miss

A miss on EPS could lead to a decline of about 4.65%, reflecting disappointment in the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in diagnostic services.
2Management's commentary on market trends and competitive landscape.
3Insights into customer acquisition and retention strategies.
4Details on cost management and operational efficiency improvements.
5Any guidance on future revenue expectations or market expansion plans.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

BillionToOne, Inc. operates in the health care sector, focusing on innovative health care services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating income.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and attract more customers, which is crucial for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BLLN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 3Q

EPS Beat Streak

EPS Beat Rate

67%

Avg EPS Surprise

+1110.58%

Avg Stock Reaction

+1.25%

Last Quarter Recap

In Q1-2026, BillionToOne reported an impressive EPS of $0.34, significantly exceeding expectations. The stock reacted positively, gaining 1.88% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic about BillionToOne's upcoming earnings, especially after a strong performance last quarter. However, uncertainty remains due to the lack of detailed guidance.

Bull Case

If BillionToOne continues to outperform expectations, particularly in EPS and revenue growth, it could solidify its position as a leader in health care diagnostics.

Bear Case

Conversely, if the company fails to meet even its previous performance, it could lead to a significant drop in investor confidence and stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the significant surprise in the last quarter, the market will closely watch EPS to gauge ongoing profitability.

How is revenue growth tracking compared to last quarter?

Revenue growth is critical for investor confidence, and any signs of slowdown could negatively impact stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

Supporting Evidence

BillionToOne's last quarter showed a remarkable EPS surprise, indicating strong operational efficiency.

The options market is pricing in a significant move, suggesting that investors expect volatility that could favor the upside.

Key Risk

If the company reports an EPS below $0.20, it could challenge the current optimistic outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be pivotal in determining whether BillionToOne can sustain its growth trajectory or if it faces headwinds.

Bull Confirmed If

An EPS of $0.40 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $0.20 would raise concerns about the company's profitability and future growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±8.89%

Historical Avg

±3.1%

Pricing rich

The options market is pricing in a substantial move, suggesting that investors expect significant volatility around the earnings report.

Options are pricing ±15.1% while BLLN has averaged ±3.1% over the last 3 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

95.0%

Calls (9K)P/C Ratio: 0.35Puts (2K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 27 (48%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If BillionToOne beats expectations, history suggests the stock could rise around 1.88%, confirming strong operational momentum.

In-Line / Cautious

If results are in line but management expresses caution, the stock may see muted movement as investors digest the commentary.

Miss

A miss on EPS could lead to a decline of about 4.65%, reflecting disappointment in the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in diagnostic services.
2Management's commentary on market trends and competitive landscape.
3Insights into customer acquisition and retention strategies.
4Details on cost management and operational efficiency improvements.
5Any guidance on future revenue expectations or market expansion plans.